Saudi health authorities to participate in trials of COVID-19 vaccines

Dubai: Saudi Arabia’s Ministry of Health said it was working with a different Chinese company to evaluate whether the vaccine it is developing is effective.

King Abdullah International Medical Research Centre (KAIMRC) in Saudi Arabia is preparing to take part in advanced trials of one or two COVID-19 vaccines.

About 40 potential vaccines are being tested on humans, nine of which are at the advanced stage of clinical trials, for safety and effectiveness in protecting people against a virus that has infected more than 31 million people around the world.

The centre confirmed its readiness to cooperate with the Kingdom’s Ministry of Health and the Saudi Food and Drug Authority (SFDA) and participate in tests of one or two of the nine vaccines that are in the third phase of clinical trials, during which large-scale testing on humans takes place.